查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球疫苗包裝市場 - 2023-2030
市場調查報告書
商品編碼
1382543

全球疫苗包裝市場 - 2023-2030

Global Vaccine Packaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球疫苗包裝市場2022年達到13億美元，預計2030年將達29億美元，2023-2030年預測期間CAGR為13.2%。

疫苗接種是現代最重要的公共衛生干預措施之一。它在根除、控制或減少從天花到脊髓灰質炎等多種致命疾病的流行方面發揮了關鍵作用。然而，疫苗的功效不僅取決於背後的科學，還取決於其安全可靠的包裝。

疫苗包裝市場是一個充滿活力的領域，涉及醫療保健、藥品和包裝材料領域。近年來，鑑於疫苗在 COVID-19 大流行期間受到關注，因為疫苗需要在特定溫度範圍內儲存以保持其效力，因此其重要性得到了放大。

初級包裝佔1/3以上的市佔率。同樣，亞太地區在疫苗包裝市場上佔據主導地位，佔據了超過 1/3 的最大市場佔有率。新興經濟體的疫苗接種機會不斷增加以及關鍵參與者的存在是該地區主導的主要原因。

動力學

先進的冷鏈物流加上永續發展與環境議題

維持冷鏈對於疫苗的有效性至關重要。疫苗必須在特定溫度下儲存和運輸，以防止變質。相應的事實導致了冷鏈物流和包裝的進步。為了滿足這項需求，Sonoco ThermoSafe 等公司推出了 Pegasus ULD 等創新包裝解決方案，專為在精確溫度下空運疫苗而設計。

此外，人們越來越重視永續性和環保的包裝解決方案。各國政府和組織正在尋找不僅實用而且對環境負責的包裝材料。 2021年，歐洲藥品管理局（EMA）強調了環保疫苗包裝的重要性。本公司已推出可回收和可生物分解的包裝選項。

增加新興市場獲得疫苗的機會

疫苗的需求不僅限於已開發國家。隨著人口和醫療保健需求的不斷成長，新興市場已成為疫苗包裝產業的重要驅動力。各國政府和組織正在努力改善這些地區獲得疫苗的機會，因此需要強大的包裝解決方案。

例如，比爾和梅琳達蓋茲基金會一直積極參與資助和支持發展中國家的疫苗接種計畫。這些措施不僅在向新興經濟體提供疫苗方面發揮著至關重要的作用，而且還增加了對疫苗包裝的需求，以將疫苗運送到這些新興經濟體。

全球疫苗接種工作不斷加強

疫苗包裝市場最重要的驅動力是全球疫苗接種的推動。隨著 COVID-19 和其他疾病的疫苗接種活動，對高效、安全和可靠的疫苗包裝的需求日益成長，以確保這些救生產品的功效。全球各國政府都在疫苗接種計畫上投入大量資金。

例如，在美國，美國疾病管制與預防中心(CDC) 報告稱，截至2021 年5 月，已接種了超過6.01 億劑新冠肺炎(COVID-19) 疫苗。相應的統計數據表明，全球疫苗接種數量不斷增加。因此，全球疫苗接種工作是市場的主要驅動力。

監理合規需求不斷成長

疫苗包裝須遵守全球衛生當局實施的嚴格規定。制定此類法規是為了確保疫苗的安全性和有效性。然而，合規性可能成為在該市場營運的公司的重大限制。滿足監管要求需要在研究、開發和品質控制方面進行大量投資。

為了應對上述挑戰，包裝公司開發了符合監管標準的解決方案。例如，Schott AG 在 2020 年推出了 iQ 平台，該平台提供了全面的品質控制方法，幫助疫苗製造商在整個包裝過程中保持合規性。

一系列冷鏈挑戰

疫苗包裝市場最重要的限制之一是需要在整個分銷過程中保持冷鏈。許多疫苗，尤其是針對麻疹、腮腺炎、德國麻疹和 COVID-19 等疾病的疫苗，需要嚴格的溫度控制才能保持有效。據世界衛生組織(WHO)稱，全球每年有高達50%的疫苗可能因運輸和儲存過程中的溫度控制問題而被浪費。

為了應對這些挑戰，出現了一些創新。例如，2020 年，Sonoco ThermoSafe 推出了 Pegasus ULD，這是專為航空運輸設計的溫控貨櫃。該產品旨在透過為疫苗和其他溫度敏感藥品的安全運輸提供可靠的解決方案來解決冷鏈問題。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按類型分類的片段
  • 按級別摘錄
  • 最終使用者的片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 先進的冷鏈物流加上永續發展與環境議題
      • 增加新興市場獲得疫苗的機會
      • 全球疫苗接種工作不斷加強
    • 限制
      • 監理合規需求不斷成長
      • 一系列冷鏈挑戰
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按類型

  • 疫苗冷藏袋
  • 小瓶和安瓿
  • 瓦楞紙箱
  • 其他

第 8 章：依級別

  • 基本的
  • 中學
  • 第三

第 9 章：最終用戶

  • 生物製藥公司
  • 醫院
  • 醫學實驗室
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Gerresheimer AG
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • West Pharmaceutical Services, Inc
  • Becton, Dickinson & Company
  • SCHOTT AG
  • SGD SA
  • Catalent, Inc
  • Stevanato Group
  • Nipro Corporation
  • Piramal Glass Private Limited
  • UDG Healthcare plc

第 13 章：附錄

簡介目錄
Product Code: PAC7469

Overview

Global Vaccine Packaging Market reached US$ 1.3 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 13.2% during the forecast period 2023-2030.

Vaccination is one of the most significant public health interventions of the modern era. It has played a pivotal role in eradicating, controlling or reducing the prevalence of numerous deadly diseases, from smallpox to polio. However, the efficacy of vaccines not only depends on the science behind them but also on their safe and secure packaging.

The vaccine packaging market is a dynamic sector that intersects the worlds of healthcare, pharmaceuticals and packaging materials. Its importance has been magnified in recent years, given the spotlight on vaccines during the COVID-19 pandemic as vaccines need to be stored within a specific temperature range to maintain their potency.

The primary packaging, accounts for over 1/3rd of the market share. Similarly, the Asia-Pacific dominates the vaccine packaging market, capturing the largest market share of over 1/3rd. Growing vaccination access to emerging economies and presence of key players are major reason behind the region's dominance.

Dynamics

Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns

Maintaining the cold chain is crucial for vaccine effectiveness. Vaccines must be stored and transported at specific temperatures to prevent spoilage. The respective fact has led to advancements in cold chain logistics and packaging. In response to this need, companies like Sonoco ThermoSafe launched innovative packaging solutions such as Pegasus ULD, designed for air cargo shipments of vaccines at precise temperatures.

Moroever, there is a growing emphasis on sustainability and environmentally friendly packaging solutions. Governments and organizations are seeking packaging materials that are not only functional but also environmentally responsible. In 2021, the European Medicines Agency (EMA) emphasized the importance of eco-friendly vaccine packaging. Companies have responded with recyclable and biodegradable packaging options.

Increasing Access to Vaccines in Emerging Markets

The need for vaccines is not limited to developed countries. Emerging markets, with growing populations and healthcare needs, have become significant drivers in the vaccine packaging industry. Governments and organizations are working to improve access to vaccines in these regions, necessitating robust packaging solutions.

For example, the Bill and Melinda Gates Foundation has been actively involved in funding and supporting vaccine delivery initiatives in developing countries. Such initiatives play crucial role in not only making vaccines available to emerging economies, but also boosts the need for vaccine packaging to transport vaccines in to these emerging economies.

Growing Global Vaccination Efforts

The most significant driver in the vaccine packaging market is the global push for vaccination. With vaccination campaigns against COVID-19 and other diseases, there is a growing need for efficient, safe and secure vaccine packaging to ensure the efficacy of these life-saving products. Governments globally are investing heavily in vaccination programs.

For instance, in U.S., the Centers for Disease Control and Prevention (CDC) reported that more than 601 million COVID-19 vaccine doses had been administered by May 2021. The respective statistics is an indicator of growing vaccination throughout the world. Thus, global vaccination efforts acts major driver for the market.

Growing Need for Regulatory Compliance

Vaccine packaging is subject to stringent regulations imposed by health authorities globally. Such regulations are in place to ensure the safety and efficacy of vaccines. However, compliance can be a significant restraint for companies operating in this market. Meeting regulatory requirements demands substantial investments in research, development and quality control.

In response to the aforementioned challenges, packaging companies have developed solutions that meet regulatory standards. For instance, Schott AG introduced the iQ platform in 2020, which provides a comprehensive approach to quality control, helping vaccine manufacturers maintain compliance throughout the packaging process.

A series of Cold Chain Challenges

One of the most significant restraints in the vaccine packaging market is the need to maintain a cold chain throughout the distribution process. Many vaccines, especially those for diseases like measles, mumps, rubella and COVID-19, require strict temperature control to remain effective. According to the World Health Organization (WHO), up to 50% of vaccines may be wasted globally each year due to temperature control issues during transportation and storage.

In response to these challenges, several innovations have emerged. In 2020, for example, Sonoco ThermoSafe introduced the Pegasus ULD, a temperature-controlled container designed for air transport. The product aims to address cold chain issues by providing a reliable solution for the safe transport of vaccines and other temperature-sensitive pharmaceuticals.

Segment Analysis

The global vaccine packaging market is segmented based on type, level, end-user and region.

Growing need to ensure safe and effective distribution of vaccines

The global vaccine packaging market plays a crucial role in ensuring the safe and effective distribution of vaccines globally. Within this market, the segment dedicated to vaccine cool bags is of paramount importance. Such products are designed to maintain the required temperature for vaccines during transportation and storage, addressing one of the most critical challenges in vaccine distribution.

The World Health Organization (WHO) estimates that over 50% of vaccines are wasted each year due to temperature deviations. The startling figure emphasizes the need for robust temperature control measures during vaccine distribution. In U.S., the Centers for Disease Control and Prevention (CDC) has reported that vaccine wastage due to temperature issues can range from 25% to 50%.

The statistics from government sources highlight the challenges faced in vaccine distribution due to temperature deviations, emphasizing the need for effective temperature control solutions. As the world continues to grapple with the importance of vaccination in public health, vaccine cool bags play a pivotal role in ensuring that vaccines reach their intended recipients in safe and effective conditions.

Geographical Penetration

Increasing Vaccine Production, Rising Healthcare Awareness and A Growing Focus On Quality and Safety In the Pharmaceutical Sector

Asia-Pacific has emerged as a key player in the global vaccine packaging market, driven by a combination of factors including increasing vaccine production, rising healthcare awareness and a growing focus on quality and safety in the pharmaceutical sector. The importance of vaccine packaging cannot be overstated. It plays a crucial role in preserving the potency and efficacy of vaccines, ensuring that they reach patients in optimal condition.

Asia-Pacific has rapidly evolved into a hub for vaccine production. With countries such as India and China at the forefront, the region manufactures a significant portion of the world's vaccines. The respective development has naturally spurred growth in the vaccine packaging sector. Moreover, government investments and initiatives aimed at bolstering the pharmaceutical sector have further fueled the vaccine packaging market's growth.

While the Asia-Pacific has made significant strides in vaccine packaging, it's not without its challenges. Ensuring the quality and safety of vaccine packaging materials, as well as meeting the increasing demand for vaccines, are ongoing concerns. However, with government support, private sector innovation and a growing awareness of the importance of vaccine packaging, the Asia-Pacific is poised for continued growth in this vital sector.

Competitive Landscape

The major global players in the market are: Gerresheimer AG, West Pharmaceutical Services, Inc, Becton, Dickinson & Company, SCHOTT AG, SGD S.A., Catalent, Inc, Stevanato Group, Nipro Corporation, Piramal Glass Private Limited and UDG Healthcare plc.

COVID-19 Impact Analysis

The COVID-19 pandemic, which began in late 2019, has had profound effects on every aspect of our lives, including the healthcare and pharmaceutical industries. One of the critical components of the global response to the pandemic has been the development and distribution of vaccines. The vaccine packaging industry plays a pivotal role in ensuring the safe and efficient delivery of vaccines globally.

The COVID-19 pandemic triggered an unprecedented global demand for vaccines. Pharmaceutical companies raced to develop vaccines to combat the virus, leading to a significant increase in vaccine production. The respective surge in vaccine production, in turn, had a direct impact on the vaccine packaging market.

According to U.S. Food and Drug Administration (FDA), as of December 2020, over 250 COVID-19 vaccine candidates were in various stages of development. The aforementioned statistics is translated to an enormous demand for vaccine packaging materials such as vials, ampoules, syringes and vial seals. Companies were forced to develop packaging solutions that could ensure the safe storage and transportation of vaccines at various temperature requirements.

Russia-Ukraine War Impact Analysis

Armed conflicts in key manufacturing regions, such as Ukraine, can disrupt global supply chains. Ukraine, for example, is known for its production of pharmaceutical and chemical products, including packaging materials. Any interruptions in the supply of materials from conflict zones can lead to shortages and increased prices for packaging materials, affecting vaccine production and distribution.

Further, global supply chain disruptions often lead to increased transportation and logistics costs. Manufacturers may need to find alternative suppliers or transportation routes, which can result in higher expenses. Such increased costs may be passed on to consumers, healthcare providers and governments purchasing vaccines.

Moroever, the eopolitical instability can also lead to regulatory challenges. Regulatory agencies in various countries may impose stricter controls or inspections on products originating from or passing through conflict zones. Such additional requirements can create delays in getting vaccines to market.

By Type

  • Vaccine Cool Bags
  • Vials and Ampoules
  • Corrugated Boxes
  • Others

By Level

  • Primary
  • Secondary
  • Tertiary

By End-User

  • Biopharmaceutical Companies
  • Hospitals
  • Medical Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In 2023, Va-Q-tec, a portable and reusable temperature-controlled packaging solution lunched COOLPACK, a vaccine cool bag designed for the safe transportation of vaccines, particularly in regions with limited infrastructure. The COOLPACK's innovative design allows it to maintain temperature for extended periods, addressing the challenges of vaccine distribution in remote areas.
  • In 2021, Sonoco ThermoSafe introduced the Pegasus ULD, a unit load device designed for the air transportation of temperature-sensitive pharmaceuticals, including vaccines. The product features advanced insulation and phase change materials, ensuring precise temperature control and protection during air travel, which is crucial for the global distribution of vaccines.
  • Softbox introduced the Tempcell ECO in 2022. The product is a single-use, fully-recyclable packaging solution, designed for the transportation of temperature-sensitive pharmaceuticals and vaccines. It offers temperature control for up to 168 hours, making it ideal for long-distance vaccine distribution.

Why Purchase the Report?

  • To visualize the global vaccine packaging market segmentation based on type, level, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of vaccine packaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global vaccine packaging market report would provide approximately 61 tables, 59 figures and 192 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Level
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns
      • 4.1.1.2. Increasing Access to Vaccines in Emerging Markets
      • 4.1.1.3. Growing Global Vaccination Efforts
    • 4.1.2. Restraints
      • 4.1.2.1. Growing Need for Regulatory Compliance
      • 4.1.2.2. A series of Cold Chain Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Vaccine Cool Bags*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Vials and Ampoules
  • 7.4. Corrugated Boxes
  • 7.5. Others

8. By Level

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 8.1.2. Market Attractiveness Index, By Level
  • 8.2. Primary*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Secondary
  • 8.4. Tertiary

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Biopharmaceutical Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals
  • 9.4. Medical Laboratories
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Gerresheimer AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. West Pharmaceutical Services, Inc
  • 12.3. Becton, Dickinson & Company
  • 12.4. SCHOTT AG
  • 12.5. SGD S.A.
  • 12.6. Catalent, Inc
  • 12.7. Stevanato Group
  • 12.8. Nipro Corporation
  • 12.9. Piramal Glass Private Limited
  • 12.10. UDG Healthcare plc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us